The world is at its toes to witness the largest clinical trial to see whether taking aspirin every day for five years can stop recurrence of cancer or not.
Fiona Reddington, Cancer Research UK’s head of population research, said: “Aspirin’s possible effects on cancer are interesting and we hope this trial will give us a clear answer on whether the drug helps stop some cancers coming back or not.”
This is the third phase of the trial and will include 11000 patients who are taking treatments or have recently had bowel, breast, oesophagus, prostate or stomach cancer. The patients will be divided into groups and then given a different measurement of doses. A 300mg daily dose of aspirin for one, a group taking 100mg every day and another group taking placebo or dummy drugs.
The researchers have already found aspirin preventing heart attacks and strokes in some people. They suggest it could prevent some types of cancer too if the trials outcome is positive.